文献速递骨肌神经MR

铁羧葡胺在臂丛MR神经成像中的诊断价值

Exploring the Diagnostic Utility of Ferumoxytol for Brachial Plexus MR Neurography.
PubMed 文献 · Radiology · 2026-01-01

本研究前瞻性纳入18例疑诊Parsonage-Turner综合征或胸廓出口综合征的参与者,比较非增强、钆增强与铁羧葡胺增强三维臂丛MR神经成像。铁羧葡胺增强在血管抑制方面优于非增强和钆增强扫描,且部分神经分支清晰度优于非增强扫描,神经异常检出与钆增强扫描无差异。

要点

  • 铁羧葡胺增强臂丛MRN可更有效抑制血管信号,减少血管对神经显示的干扰。
  • 铁羧葡胺增强对肩胛上、腋、胸长神经部分节段的清晰度优于非增强扫描。
  • 铁羧葡胺增强在神经异常检出上与钆增强扫描表现相当,可用于替代钆对比剂。

核心结论

  • 铁羧葡胺增强臂丛MRN的血管抑制优于非增强和钆增强三维短时反转恢复快速自旋回波序列。
  • 铁羧葡胺增强较非增强扫描提高了肩胛上、腋、胸长神经部分节段的清晰度,与钆增强扫描神经异常检出无差异。

研究设计与样本

  • 前瞻性研究,纳入18例疑诊Parsonage-Turner综合征或胸廓出口综合征参与者,平均年龄42岁±15.2,男性10例。
  • 参与者在临床检查后3个月内接受铁羧葡胺增强三维MRN,部分同时接受钆对比剂增强和/或非增强三维MRN。
  • 两名肌骨放射科医师对三维短时反转恢复快速自旋回波序列进行定性评价。
  • 统计学采用Wilcoxon符号秩检验或McNemar检验。

关键影像表现/征象

  • 铁羧葡胺增强扫描较非增强扫描(两名阅片者均P<.001)和钆增强扫描(两名阅片者均P=.04)显示更好的血管抑制。
  • 阅片者2评价铁羧葡胺增强较非增强扫描改善了肩胛上神经(P=.01)、腋神经(P=.02)和胸长神经(P=.004)节段的清晰度。
  • 阅片者1对上述神经节段的评分分布也倾向于铁羧葡胺增强优于非增强扫描,但差异未达到统计学意义(均P≥.06)。
  • 铁羧葡胺增强与钆增强扫描在神经清晰度方面无差异证据(所有神经节段P≥.17)。
  • 铁羧葡胺增强与钆增强扫描在神经异常检出方面无差异证据(均P≥.48)。

临床应用与阅片要点

  • 铁羧葡胺可用于臂丛MRN中替代钆对比剂实现血管抑制,特别适用于无法使用钆对比剂的患者。
  • 阅片时重点观察肩胛上、腋、胸长神经节段,铁羧葡胺增强较非增强扫描更易辨认这些神经。

局限性

  • 样本量仅18例,且为单中心前瞻性设计。
  • 读片者间对神经清晰度的评价结果不完全一致,阅片者1的部分差异未达统计学意义。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Ferumoxytol has been described as an alternative contrast agent for vascular suppression in MR neurography (MRN), but its diagnostic utility in patients has yet to be evaluated. Purpose To evaluate the impact of ferumoxytol on vascular suppression, nerve conspicuity, and evaluation of nerve abnormalities at three-dimensional (3D) brachial plexus MRN, compared with noncontrast and gadolinium-enhanced MRN, in participants with suspected Parsonage-Turner syndrome (PTS) or thoracic outlet syndrome (TOS). Materials and Methods This prospective study included participants who underwent 3D MRN with and/or without gadolinium chelate for clinical suspicion of PTS or TOS and subsequently underwent 3D MRN with ferumoxytol (within 3 months of the clinical examination). Two musculoskeletal radiologists qualitatively evaluated 3D short-tau inversion-recovery fast spin-echo scans for the degree of vascular suppression, nerve conspicuity, and presence of nerve abnormalities. Wilcoxon signed-rank or McNemar tests were used for comparing noncontrast and gadolinium-enhanced scans with ferumoxytol-enhanced scans. Results This study included 18 participants (mean age, 42 years ± 15.2 [SD]; 10 men). Ferumoxytol-enhanced scans demonstrated improved vascular suppression compared with both noncontrast scans (both raters, P < .001) and gadolinium-enhanced scans (both P = .04). For rater 2, ferumoxytol-enhanced acquisitions demonstrated improved conspicuity of several nerve segments relative to the noncontrast scan, including segments of the suprascapular (P = .01), axillary (P = .02), and long thoracic nerves (P = .004). The distribution of scores for these nerve segments for rater 1 also favored ferumoxytol-enhanced versus noncontrast scans, but the differences were not statistically significant (all P ≥ .06). There was no evidence of a difference in nerve conspicuity between ferumoxytol-enhanced and gadolinium-enhanced scans (P ≥ .17 for all nerve segments) and also no evidence of discrepancies in abnormal nerve findings between the acquisitions (all P ≥ .48). Conclusion Ferumoxytol improved vascular suppression compared with noncontrast and gadolinium-enhanced 3D short-tau inversion-recovery fast spin-echo sequences in brachial plexus MRN, enhancing the conspicuity of several nerve branches versus noncontrast scans, with similar detection of abnormal nerve findings. © RSNA, 2026 Supplemental material is available for this article.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Ensle, Tan, Queler, et al. Exploring the Diagnostic Utility of Ferumoxytol for Brachial Plexus MR Neurography. Radiology. 2026. PMID: 42678261. doi:10.1148/radiol.254051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。